Starpharma Holdings Limited has two operating entities, Starpharma Pty Ltd, based in Melbourne, Australia, and Dendritic Nanotechnologies Inc which is a wholly owned subsidiary based in Michigan, US.
100% |
|
100% |
|
|
Based in Melbourne, Australia
Leading developer of dendrimers as pharmaceuticals, drug delivery and targeted diagnostics
Lead development product, VivaGel® is a vaginal microbicide for the prevention of genital herpes and HIV
|
Based in Michigan, USA
Leading developer of dendrimers for life science, industrial & materials applications
Existing licensing agreements with established revenue streams for dendrimer technology
|
